Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency
NCT ID: NCT02293759
Last Updated: 2016-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2014-10-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients with bleeding tendency will be offered either HoLEP or Greenlight laser PVP based on prostate size cut off point of 80ml Larger prostates will be treated with HoLEP Smaller prostates will be treated with greenlight PVP
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH
NCT02332538
HoLEP vs BipolEP in Management of BPH Patients With Large Prostates
NCT06759194
HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH
NCT02737241
HoLEP in Management of BPH Patients With Predominant Voiding vs Storage LUTS: A Comparative Retrospective Study
NCT04178811
HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial
NCT04143399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Strict antiplatelet intake
2. Strict anticoagulant intake
3. uncorrected natural bleeding tendency e.g; patients with liver cell failure are at higher risk of perioperative bleeding when subjected to prostate surgery.
Laser prostate surery was introduced to overcome this difficulty. However, till now there is no head to head comparision of different types of laser procedures in treating this subset of patients In the current study patients presented for BPH surgery in a tertiarry referral prostate unit will be assessed for bleeding tendency and will be treated either by Holmium laser enucleatiuon of the prostate or Greenlight laser vaporization of the prostate Single surgeon will perform all cases
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HoLEP
Holmium laser enucleation of the prostate
HoLEP
Holmium laser enucleation of the prsotate
Greenlight laser PVP
Phtoselective vaporization of the prostate
Greenlight laser PVP
Greenlight laser (532nm) Photoslective vaporization of the prostate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HoLEP
Holmium laser enucleation of the prsotate
Greenlight laser PVP
Greenlight laser (532nm) Photoslective vaporization of the prostate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Perioperative uncorrected Blleding tendency
1. patients with naturally induced uncorrectable bleeding tendency;
1. platelet count less than 100000/mm3
2. INR more than 1.5
2. Patients on oral antiplatlet that deemed unsafe to stop prior to surgery as per intenist
3. Patients on oral anticoagulant that deemed unsafe to stop prior to surgery as per intenist
Exclusion Criteria
50 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Elshal
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed m Elshal, MD
Role: PRINCIPAL_INVESTIGATOR
Mansoura University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology and Nephrology Center
Al Mansurah, Aldakahlia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mans-2014-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.